AstraZeneca Covid-19 vaccine trial on hold over safety concern – STAT News
|Early Wednesday morning in Asia, global markets got another blow to the risk-tone sentiment as AstraZeneca halts the phase 3 trials for the coronavirus (COVID-19) vaccine citing a suspected serious adverse reaction in a participant in the United Kingdom, per STAT news.
Key quotes
A spokesperson for AstraZeneca, a frontrunner in the race for a Covid-19 vaccine, said in a statement that the company’s ‘standard review process triggered a pause to vaccination to allow review of safety data.’
It was not immediately clear who placed the hold on the trial, though it is possible it was placed voluntarily by AstraZeneca and not ordered by any regulatory agency.
The nature of the adverse reaction and when it happened were also not immediately known, though the participant is expected to recover, according to an individual familiar with the matter.
The spokesperson described the pause as ‘a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.’
The spokesperson also said that the company is ‘working to expedite the review of the single event to minimize any potential impact on the trial timeline.’
FX implications
While portraying the risk aversion wave, S&P 500 Futures drop 0.60% to 3,314 by the press time.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.